IL-1β Disrupts Postnatal Lung Morphogenesis in the Mouse
暂无分享,去创建一个
[1] K. Wada,et al. Bombesin inhibits alveolarization and promotes pulmonary fibrosis in newborn mice. , 2006, American journal of respiratory and critical care medicine.
[2] R. Simon,et al. Expression of the reverse tetracycline-transactivator gene causes emphysema-like changes in mice. , 2006, American journal of respiratory cell and molecular biology.
[3] P. Dekoninck,et al. Growth of pulmonary microvasculature in ventilated preterm infants. , 2006, American journal of respiratory and critical care medicine.
[4] J. Whitsett,et al. Conditional recombination reveals distinct subsets of epithelial cells in trachea, bronchi, and alveoli. , 2005, American journal of respiratory cell and molecular biology.
[5] H. Kurihara,et al. Temporal Expression of Alpha–Smooth Muscle Actin and Drebrin in Septal Interstitial Cells during Alveolar Maturation , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[6] B. Vohr,et al. Vitamin A Supplementation for Extremely Low Birth Weight Infants: Outcome at 18 to 22 Months , 2005, Pediatrics.
[7] J. Tichelaar,et al. Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. , 2005, American journal of respiratory cell and molecular biology.
[8] A. Tanswell,et al. Opposing effects of 60% oxygen and neutrophil influx on alveologenesis in the neonatal rat. , 2004, American journal of respiratory and critical care medicine.
[9] H. Coxson,et al. Early emphysema in patients with anorexia nervosa. , 2004, American journal of respiratory and critical care medicine.
[10] U. Pastorino,et al. Primary human alveolar type II epithelial cell chemokine release: effects of cigarette smoke and neutrophil elastase. , 2004, American journal of respiratory cell and molecular biology.
[11] J. Major,et al. Neutrophil chemoattractant genes KC and MIP‐2 are expressed in different cell populations at sites of surgical injury , 2004, Journal of leukocyte biology.
[12] R. Sue,et al. CXCR2 Is Critical to Hyperoxia-Induced Lung Injury1 , 2004, The Journal of Immunology.
[13] R. Auten,et al. Antimacrophage chemokine treatment prevents neutrophil and macrophage influx in hyperoxia-exposed newborn rat lung. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[14] K. Kaestner,et al. Foxa2 regulates alveolarization and goblet cell hyperplasia , 2004, Development.
[15] R. Baier,et al. CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia , 2004, Pediatric pulmonology.
[16] A. Choi. American journal of respiratory cell and molecular biology: Introduction , 2003 .
[17] J. Coalson. Pathology of new bronchopulmonary dysplasia. , 2003, Seminars in neonatology : SN.
[18] M. Burdick,et al. Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. , 2002, The Journal of clinical investigation.
[19] R. Strieter,et al. CXC chemokines in angiogenesis related to pulmonary fibrosis. , 2002, Chest.
[20] A. Jobe,et al. Decreased Indicators of Lung Injury with Continuous Positive Expiratory Pressure in Preterm Lambs , 2002, Pediatric Research.
[21] D. Massaro,et al. Lung alveoli: endogenous programmed destruction and regeneration. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[22] K. Geering,et al. Human nongastric H+-K+-ATPase: transport properties of ATP1al1 assembled with different beta-subunits. , 2002, American journal of physiology. Cell physiology.
[23] R. Watkins,et al. Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[24] R. Watkins,et al. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. , 2001, American journal of respiratory and critical care medicine.
[25] D. McDonald,et al. Angiogenesis and remodeling of airway vasculature in chronic inflammation. , 2001, American journal of respiratory and critical care medicine.
[26] J. White,et al. Nonpeptide CXCR2 antagonist prevents neutrophil accumulation in hyperoxia-exposed newborn rats. , 2001, The Journal of pharmacology and experimental therapeutics.
[27] Stark Ar. 超出生体重児に対する早期デキサメサゾン投与の有用性 : National Institute of Child Health and Human Development Neonatal research Network報告 (海外誌掲載論文の和文概要とそれに対するコメント) , 2001 .
[28] S. Abrams. Chronic pulmonary insufficiency in children and its effects on growth and development. , 2001, The Journal of nutrition.
[29] W. Poole,et al. Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. , 2001, The New England journal of medicine.
[30] R. Auten,et al. Lung inflammation in hyperoxia can be prevented by antichemokine treatment in newborn rats. , 2000, American journal of respiratory and critical care medicine.
[31] B. Yoder,et al. High-frequency oscillatory ventilation: effects on lung function, mechanics, and airway cytokines in the immature baboon model for neonatal chronic lung disease. , 2000, American journal of respiratory and critical care medicine.
[32] R. Bland,et al. Chronic Lung Disease in Early Infancy , 2000 .
[33] M. Keating,et al. Impaired distal airway development in mice lacking elastin. , 2000, American journal of respiratory cell and molecular biology.
[34] N. Voelkel,et al. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[35] J. Hauth,et al. Intrauterine infection and preterm delivery. , 2000, The New England journal of medicine.
[36] J. Tichelaar,et al. Conditional Expression of Fibroblast Growth Factor-7 in the Developing and Mature Lung* , 2000, The Journal of Biological Chemistry.
[37] W. Webb,et al. High-resolution inspiratory and expiratory CT in older children and adults with bronchopulmonary dysplasia. , 1999, AJR. American journal of roentgenology.
[38] B. Yoder,et al. Neonatal chronic lung disease in extremely immature baboons. , 1999, American journal of respiratory and critical care medicine.
[39] G. Verleden,et al. Expression of monocyte chemotactic protein (MCP)-1, MCP-2, and MCP-3 by human airway smooth-muscle cells. Modulation by corticosteroids and T-helper 2 cytokines. , 1999, American journal of respiratory cell and molecular biology.
[40] K. Osanai,et al. Effects of interleukin‐1β on DNA synthesis in rat alveolar type II cells in primary culture , 1999 .
[41] D. Carlton,et al. Chronic lung injury in preterm lambs. Disordered respiratory tract development. , 1999, American journal of respiratory and critical care medicine.
[42] P. Libby,et al. Generation of Biologically Active IL-1β by Matrix Metalloproteinases: A Novel Caspase-1-Independent Pathway of IL-1β Processing , 1998, The Journal of Immunology.
[43] K. Wenstrom,et al. Elevated second-trimester amniotic fluid interleukin-6 levels predict preterm delivery. , 1998, American journal of obstetrics and gynecology.
[44] B. Rollins,et al. Abnormalities in Monocyte Recruitment and Cytokine Expression in Monocyte Chemoattractant Protein 1–deficient Mice , 1998, The Journal of experimental medicine.
[45] C. Betsholtz,et al. Alveogenesis failure in PDGF-A-deficient mice is coupled to lack of distal spreading of alveolar smooth muscle cell progenitors during lung development. , 1997, Development.
[46] A. Hakulinen,et al. Bronchial lability and responsiveness in school children born very preterm. , 1997, American journal of respiratory and critical care medicine.
[47] F. Ghezzi,et al. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-⍺, interleukin-1β, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia , 1997 .
[48] M. Hallman,et al. Intraamniotic interleukin-1 accelerates surfactant protein synthesis in fetal rabbits and improves lung stability after premature birth. , 1997, The Journal of clinical investigation.
[49] R. Pierce,et al. Chronic lung injury in preterm lambs: disordered pulmonary elastin deposition. , 1997, The American journal of physiology.
[50] S. Baron,et al. Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class I MHC expression through the induction of IFN-beta and IL-1 alpha. , 1996, Journal of immunology.
[51] M. Silverman,et al. Increase in Interleukin (IL)-1β and IL-6 in Bronchoalveolar Lavage Fluid Obtained from Infants with Chronic Lung Disease of Prematurity , 1996, Pediatric Research.
[52] C. Dinarello,et al. Biologic basis for interleukin-1 in disease. , 1996, Blood.
[53] K. Watterberg,et al. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. , 1996, Pediatrics.
[54] P. Proost,et al. Human monocyte chemotactic proteins‐2 and ‐3: structural and functional comparison with MCP‐1 , 1996, Journal of leukocyte biology.
[55] Armen B. Shanafelt,et al. The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis (*) , 1995, The Journal of Biological Chemistry.
[56] M. Silverman,et al. Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease. , 1995, Archives of disease in childhood. Fetal and neonatal edition.
[57] J. Whitsett,et al. SP-A deficiency in primate model of bronchopulmonary dysplasia with infection. In situ mRNA and immunostains. , 1995, American journal of respiratory and critical care medicine.
[58] S. Shapiro,et al. Elastolytic metalloproteinases produced by human mononuclear phagocytes. Potential roles in destructive lung disease. , 1994, American journal of respiratory and critical care medicine.
[59] R. Romero,et al. Interleukin‐1α and Interleukin‐1 β in Preterm and Term Human Parturition , 1992 .
[60] E. S. Kimball,et al. Angiogenesis in pannus formation , 1991, Agents and Actions.
[61] S. Shapiro,et al. Human 92- and 72-kilodalton type IV collagenases are elastases. , 1991, The Journal of biological chemistry.
[62] K. Leslie,et al. Alpha smooth muscle actin expression in developing and adult human lung. , 1990, Differentiation; research in biological diversity.
[63] I. Hemo,et al. In vivo angiogenic activity of interleukins. , 1990, Archives of ophthalmology.
[64] B. Quednow,et al. Influence of milk on the bioavailability of doxycycline — new aspects , 1989, Infection.
[65] R. Guthrie,et al. Early onset of airway reactivity in premature infants with bronchopulmonary dysplasia. , 1987, The American review of respiratory disease.
[66] D. Strayer,et al. Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia. , 1983, The Journal of clinical investigation.
[67] L. Monte,et al. [Bronchopulmonary dysplasia]. , 2005, Jornal de pediatria.
[68] J. Crapo,et al. A catalytic antioxidant attenuates alveolar structural remodeling in bronchopulmonary dysplasia. , 2003, American journal of respiratory and critical care medicine.
[69] K. Osanai,et al. Effects of interleukin-1 beta on DNA synthesis in rat alveolar type II cells in primary culture. , 1999, Respirology.
[70] P. Libby,et al. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. , 1998, Journal of immunology.
[71] F. Ghezzi,et al. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. , 1997, American journal of obstetrics and gynecology.
[72] R. Romero,et al. Interleukin-1 alpha and interleukin-1 beta in preterm and term human parturition. , 1992, American journal of reproductive immunology.